BIOREM Inc.
BRM.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 67.53% | 18.97% | -1.12% | -15.43% | -21.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 67.53% | 18.97% | -1.12% | -15.43% | -21.68% |
| Cost of Revenue | 56.91% | 17.11% | -4.16% | -12.62% | -19.01% |
| Gross Profit | 95.81% | 23.48% | 6.36% | -21.93% | -28.00% |
| SG&A Expenses | 11.65% | -20.34% | -28.63% | -34.29% | 5.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3,600.00% | -500.00% | -500.00% | -500.00% | -- |
| Total Operating Expenses | 46.80% | 8.30% | -9.85% | -17.65% | -14.82% |
| Operating Income | 388.61% | 152.87% | 102.48% | 4.80% | -65.16% |
| Income Before Tax | 545.93% | 217.50% | 120.38% | 14.69% | -71.61% |
| Income Tax Expenses | 298.31% | 106.65% | 49.11% | -21.72% | -64.22% |
| Earnings from Continuing Operations | 710.35% | 280.80% | 157.71% | 32.04% | -75.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 710.35% | 280.80% | 157.71% | 32.04% | -75.04% |
| EBIT | 388.61% | 152.87% | 102.48% | 4.80% | -65.16% |
| EBITDA | 345.50% | 129.20% | 83.49% | 0.07% | -63.03% |
| EPS Basic | 691.83% | 271.33% | 151.92% | 29.63% | -64.95% |
| Normalized Basic EPS | 531.45% | 209.43% | 115.05% | 12.45% | -59.64% |
| EPS Diluted | 762.45% | 358.63% | 196.30% | 42.47% | -68.22% |
| Normalized Diluted EPS | 716.06% | 272.12% | 148.27% | 20.13% | -70.10% |
| Average Basic Shares Outstanding | 0.66% | 0.82% | 1.18% | 1.54% | -14.80% |
| Average Diluted Shares Outstanding | 5.43% | 4.70% | -1.65% | -4.83% | -12.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
